Literature DB >> 22427130

Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).

Valentina Volynets1, Markus A Küper, Stefan Strahl, Ina B Maier, Astrid Spruss, Sabine Wagnerberger, Alfred Königsrainer, Stephan C Bischoff, Ina Bergheim.   

Abstract

BACKGROUND: A role of an altered dietary pattern (e.g., a diet rich in sugar) but also alterations at the level of the intestinal barrier have repeatedly been discussed to be involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). AIMS: To determine if the nutritional intake, intestinal flora, and permeability and the development of NAFLD are related in humans.
METHODS: Ten controls and 20 patients with NAFLD ranging from simple steatosis to steatohepatitis were included in the study. Bacterial overgrowth, orocecal transit time, and intestinal permeability were assessed. Alcohol, endotoxin, and plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma. Nutritional intake was assessed using a dietary history.
RESULTS: Despite no differences in the prevalence of bacterial overgrowth and in the orocecal transit time, intestinal permeability, alcohol, and endotoxin levels in plasma were significantly higher in patients with NAFLD than in controls. Similar results were also found for PAI-1 plasma concentrations. Patients with NAFLD had a significantly higher intake of protein, total carbohydrates, and mono- as well as disaccharides than controls. PAI-1, endotoxin, and ALT plasma levels were positively related to total protein and carbohydrate intake.
CONCLUSIONS: Taken together, our results indicate that intestinal permeability, endogenous alcohol synthesis, and nutritional intake are markedly altered in patients with NAFLD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427130     DOI: 10.1007/s10620-012-2112-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  Oxidative stress and antioxidant status in mouse liver: effects of dietary lipid, vitamin E and iron.

Authors:  W Ibrahim; U S Lee; C C Yeh; J Szabo; G Bruckner; C K Chow
Journal:  J Nutr       Date:  1997-07       Impact factor: 4.798

2.  Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.

Authors:  Mika Yamamoto; Motoh Iwasa; Kazuko Iwata; Masahiko Kaito; Ryosuke Sugimoto; Naohito Urawa; Rumi Mifuji; Masayoshi Konishi; Yoshinao Kobayashi; Yukihiko Adachi
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

3.  Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time.

Authors:  S J La Brooy; P J Male; A K Beavis; J J Misiewicz
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

4.  Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

Authors:  Hellan Kang; Joel K Greenson; Jason T Omo; Cewin Chao; Debra Peterman; Lilian Anderson; Laura Foess-Wood; Mary A Sherbondy; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

5.  Increased orocecal transit time in patients with nonalcoholic fatty liver disease.

Authors:  Alejandro Soza; Arnoldo Riquelme; Robinson González; Manuel Alvarez; Rosa María Pérez-Ayuso; Juan Carlos Glasinovic; Marco Arrese
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

6.  Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.

Authors:  K J Taylor; C A Riely; L Hammers; S Flax; G Weltin; G Garcia-Tsao; H O Conn; R Kuc; K W Barwick
Journal:  Radiology       Date:  1986-07       Impact factor: 11.105

7.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

8.  Intestinal permeability is increased in patients with advanced cirrhosis.

Authors:  Sonia Pascual; José Such; Angel Esteban; Pedro Zapater; Juan A Casellas; José R Aparicio; Eva Girona; Ana Gutiérrez; Fernando Carnices; Jose M Palazón; Javier Sola-Vera; Miguel Pérez-Mateo
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

9.  Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.

Authors:  Marie-Christine Alessi; Delphine Bastelica; Alenka Mavri; Pierre Morange; Bruno Berthet; Michel Grino; Irene Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-15       Impact factor: 8.311

10.  Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium.

Authors:  Vishnudutt Purohit; J Christian Bode; Christiane Bode; David A Brenner; Mashkoor A Choudhry; Frank Hamilton; Y James Kang; Ali Keshavarzian; Radhakrishna Rao; R Balfour Sartor; Christine Swanson; Jerrold R Turner
Journal:  Alcohol       Date:  2008-05-27       Impact factor: 2.405

View more
  78 in total

Review 1.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 2.  Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development.

Authors:  Ilaria Peluso; Husseen Manafikhi; Raffaella Reggi; Maura Palmery
Journal:  Eur J Nutr       Date:  2015-03-16       Impact factor: 5.614

Review 3.  Gut microbiota: a new path to treat obesity.

Authors:  Giovanna Muscogiuri; Elena Cantone; Sara Cassarano; Dario Tuccinardi; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

Review 4.  Potential link between excess added sugar intake and ectopic fat: a systematic review of randomized controlled trials.

Authors:  Jiantao Ma; Micaela C Karlsen; Mei Chung; Paul F Jacques; Edward Saltzman; Caren E Smith; Caroline S Fox; Nicola M McKeown
Journal:  Nutr Rev       Date:  2015-10-29       Impact factor: 7.110

5.  Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).

Authors:  Cathrin Sellmann; Cheng Jun Jin; Anna Janina Engstler; Jean-Pascal De Bandt; Ina Bergheim
Journal:  Eur J Nutr       Date:  2016-08-05       Impact factor: 5.614

6.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

7.  Gut microbiota, fatty liver disease, and hepatocellular carcinoma.

Authors:  Huikuan Chu; Brandon Williams; Bernd Schnabl
Journal:  Liver Res       Date:  2018-02-21

8.  Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease.

Authors:  Farnush Bakhshimoghaddam; Mohammad Alizadeh
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 9.  Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.

Authors:  Fabiana de Faria Ghetti; Daiane Gonçalves Oliveira; Juliano Machado de Oliveira; Lincoln Eduardo Villela Vieira de Castro Ferreira; Dionéia Evangelista Cesar; Ana Paula Boroni Moreira
Journal:  Eur J Nutr       Date:  2017-09-05       Impact factor: 5.614

10.  Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis.

Authors:  Caroline C Duwaerts; Jacquelyn J Maher
Journal:  Curr Hepatol Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.